Q2 2018 Holdings
Filed 2018-08-10 | 106 holdings | $236.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $103.8M | 675,000 | 43.8% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $64.0M | 650,000 | 27.1% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $29.5M | 350,000 | 12.5% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $14.1M | 525,000 | 5.9% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $12.4M | 150,000 | 5.3% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $4.7M | 475,000 | 2.0% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $3.7M | 300,000 | 1.6% |
| Weight Watchers Intl Inc New | COM | 948626106 | $2.1M | 20,818,300 | 0.9% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $722.9K | 60,240,864 | 0.3% |
| Bank Amer Corp(BAC)Call | COM | 060505104 | $179.0K | 6,350,000 | 0.1% |
| Celgene Corp(CELG)Call | COM | 151020104 | $158.8K | 2,000,000 | 0.1% |
| Morgan Stanley(MS)Call | COM NEW | 617446448 | $71.1K | 1,500,000 | 0.0% |
| Bristol Myers Squibb Co(BMY)Call | COM | 110122108 | $69.2K | 1,250,000 | 0.0% |
| Goldman Sachs Group Inc(GS)Call | COM | 38141G104 | $66.2K | 300,000 | 0.0% |
| General Mtrs Co(GM)Call | COM | 37045V100 | $59.1K | 1,500,000 | 0.0% |
| Wells Fargo Co New(WFC)Call | COM | 949746101 | $55.4K | 1,000,000 | 0.0% |
| Ishares TR(IBB)Call | NASDAQ BIOTECH | 464287556 | $49.4K | 450,000 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $48.5K | 1,000,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $45.3K | 2,900,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $44.4K | 700,000 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $43.9K | 900,000 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $37.4K | 2,396,040 | 0.0% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $36.8K | 1,000,000 | 0.0% |
| Tesaro Inc | COM | 881569107 | $35.6K | 800,000 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $33.6K | 2,000,000 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $26.7K | 170,000 | 0.0% |
| Medicines CoCall | COM | 584688105 | $25.7K | 700,000 | 0.0% |
| Zogenix Inc | COM NEW | 98978L204 | $22.1K | 500,000 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $19.3K | 1,700,000 | 0.0% |
| Biomarin Pharmaceutical Inc(BMRN)Call | COM | 09061G101 | $18.8K | 200,000 | 0.0% |
| Albireo Pharma Inc(BDQM) | COM | 01345P106 | $17.8K | 500,000 | 0.0% |
| Freeport-Mcmoran Inc(FCX)Call | CL B | 35671D857 | $17.3K | 1,000,000 | 0.0% |
| Inflarx NV(IFRX) | COM | N44821101 | $16.1K | 500,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $15.7K | 100,000 | 0.0% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $15.7K | 250,000 | 0.0% |
| Tesaro IncCall | COM | 881569107 | $15.6K | 350,000 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $14.8K | 400,000 | 0.0% |
| Medicines Co | COM | 584688105 | $14.7K | 400,000 | 0.0% |
| Nektar Therapeutics(NKTREUR)Call | COM | 640268108 | $14.6K | 300,000 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $14.2K | 200,000 | 0.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $14.0K | 50,000 | 0.0% |
| Blueprint Medicines Corp(2L9)Call | COM | 09627Y109 | $12.7K | 200,000 | 0.0% |
| Zafgen Inc | COM | 98885E103 | $12.3K | 1,200,000 | 0.0% |
| Accelerate Diagnostics Inc | COM | 00430H102 | $11.2K | 500,000 | 0.0% |
| Accelerate Diagnostics IncCall | COM | 00430H102 | $11.2K | 500,000 | 0.0% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $11.0K | 1,500,000 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $10.8K | 150,000 | 0.0% |
| Exelixis Inc(EXEL)Call | COM | 30161Q104 | $10.8K | 500,000 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $10.7K | 800,000 | 0.0% |
| Alnylam Pharmaceuticals Inc(ALNY)Call | COM | 02043Q107 | $9.8K | 100,000 | 0.0% |